Literature DB >> 18027856

Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.

Bente A Talseth1, Katie A Ashton, Cliff Meldrum, Janina Suchy, Grzegorz Kurzawski, Jan Lubinski, Rodney J Scott.   

Abstract

Polymorphisms in the 2 cell-cycle control genes Aurora A and Cyclin D1 have previously been associated with changes in the age of onset of colorectal cancer in persons harboring germline mutations in DNA mismatch repair genes associated with hereditary nonpolyposis colorectal cancer (HNPCC). In this report, we have genotyped 312 individuals, who all harbored confirmed causative mutations in either hMSH2 or hMLH1, for 2 polymorphisms, one in Aurora A (T91A) and the other in Cyclin D1 (G870A). The results reveal that the previous association with the Aurora A polymorphism could not be confirmed in our larger group of HNPCC patients. The Cyclin D1 polymorphism, however, was associated with a significant difference in the age of disease onset on patients harboring hMSH2 mutations, which was not observed in hMLH1 mutation carriers. A combined analysis of the Aurora A and Cyclin D1 polymorphisms did not reveal any obvious association. In conclusion, it appears that the polymorphic variant of Aurora A does not appear to be associated with variation in colorectal cancer risk in HNPCC, whereas there is a more complex relationship between the Cyclin D1 polymorphism and disease risk in HNPCC. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18027856     DOI: 10.1002/ijc.23177

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.

Authors:  Bente A Talseth-Palmer; Mary McPhillips; Claire Groombridge; Allan Spigelman; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2010-05-21       Impact factor: 2.857

2.  Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients.

Authors:  Carolina Bonilla; Jérémie H Lefèvre; Bruce Winney; Elaine Johnstone; Susan Tonks; Chrystelle Colas; Tammy Day; Katarzyna Hutnik; Abdelhamid Boumertit; Rachel Midgley; David Kerr; Yann Parc; Walter F Bodmer
Journal:  J Hum Genet       Date:  2010-11-25       Impact factor: 3.172

3.  The significant association of CCND1 genotypes with colorectal cancer in Taiwan.

Authors:  Chung-Yu Huang; Chia-Wen Tsai; Chin-Mu Hsu; Wen-Shin Chang; Hao-Ai Shui; Da-Tian Bau
Journal:  Tumour Biol       Date:  2015-03-26

4.  Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations.

Authors:  Lou-Qian Zhang; Jun Wang; Jun-Qing Shang; Jian-Ling Bai; Fu-Yin Liu; Xin Guan; Jian-Nong Zhou
Journal:  Int J Colorectal Dis       Date:  2011-05-05       Impact factor: 2.571

5.  A functional variant of IC53 correlates with the late onset of colorectal cancer.

Authors:  Jingzhou Chen; Yi Shi; Ziyu Li; Hui Yu; Yu Han; Xiaojian Wang; Kai Sun; Tao Yang; Kejia Lou; Yan Song; Yinhui Zhang; Yisong Zhen; Guiguo Zhang; Ying Hu; Jiafu Ji; Rutai Hui
Journal:  Mol Med       Date:  2011-03-02       Impact factor: 6.354

6.  Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome.

Authors:  Jinyun Chen; Carol J Etzel; Christopher I Amos; Qing Zhang; Nancy Viscofsky; Noralane M Lindor; Patrick M Lynch; Marsha L Frazier
Journal:  Cancer Causes Control       Date:  2009-08-19       Impact factor: 2.506

7.  CCND1 G870A polymorphism and colorectal cancer risk: An updated meta-analysis.

Authors:  Xiao-Ming Xu; Xiao-Bing Ni; Gong-Li Yang; Zhi-Guo Luo; Yu-Ming Niu; Ming Shen
Journal:  Mol Clin Oncol       Date:  2016-04-04

8.  SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.

Authors:  Viktor Komlósi; Erika Hitre; Eva Pap; Vilmos Adleff; Andrea Réti; Eva Székely; Anna Bíró; Péter Rudnai; Bernadette Schoket; Judit Müller; Béla Tóth; Szabolcs Ottó; Miklós Kásler; Judit Kralovánszky; Barna Budai
Journal:  BMC Cancer       Date:  2010-10-04       Impact factor: 4.430

9.  Anticipation in lynch syndrome: where we are where we go.

Authors:  Cristina Bozzao; Patrizia Lastella; Alessandro Stella
Journal:  Curr Genomics       Date:  2011-11       Impact factor: 2.236

Review 10.  Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.

Authors:  Yongzhi Yang; Feng Wang; Chenzhang Shi; Yang Zou; Huanlong Qin; Yanlei Ma
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.